Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Novel therapeutics acting via purine receptors.

Literature DB >> 2018549

Novel therapeutics acting via purine receptors.

K A Jacobson¹, B K Trivedi, P C Churchill, M Williams.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1991 PMID： 2018549 PMCID： PMC3561777 DOI： 10.1016/0006-2952(91)90555-j

Source DB: PubMed Journal: Biochem Pharmacol ISSN： 0006-2952 Impact factor: 5.858

× No keyword cloud information.

44 in total

1. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.

Authors: J E Francis; W D Cash; S Psychoyos; G Ghai; P Wenk; R C Friedmann; C Atkins; V Warren; P Furness; J L Hyun
Journal: J Med Chem Date: 1988-05 Impact factor: 7.446

2. The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure.

Authors: J O DAVIS; N W SHOCK
Journal: J Clin Invest Date: 1949-11 Impact factor: 14.808

3. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.

Authors: R D Murray; P C Churchill
Journal: J Pharmacol Exp Ther Date: 1985-01 Impact factor: 4.030

4. CGP 22979A, a renal vasodilator with natriuretic properties.

Authors: K G Hofbauer; C Sonnenburg; R Stalder; L Criscione; J Kraetz; W Fuhrer; E Habicht
Journal: J Pharmacol Exp Ther Date: 1985-03 Impact factor: 4.030

5. Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.

Authors: A Wauquier; H Van Belle; W A Van den Broeck; P A Janssen
Journal: Psychopharmacology (Berl) Date: 1987 Impact factor: 4.530

6. Coronary and cardiohemodynamic effects of 2-phenylamino-adenosine (CV-1808) in anesthetized dogs and cats.

Authors: K Kawazoe; N Matsumoto; M Tanabe; S Fujiwara; M Yanagimoto; M Hirata; K Kikuchi
Journal: Arzneimittelforschung Date: 1980

7. Impaired blood flow autoregulation in nonfiltering kidneys: effects of theophylline administration.

Authors: J L Osborn; L G Hoversten; G F DiBona
Journal: Proc Soc Exp Biol Med Date: 1983-12

8. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia.

Authors: R Engler
Journal: Fed Proc Date: 1987-05-15

9. Adenosine stimulates sodium transport in kidney A6 epithelia in culture.

Authors: M A Lang; A S Preston; J S Handler; J N Forrest
Journal: Am J Physiol Date: 1985-09

10. Adenosine receptors and behavioral actions of methylxanthines.

Authors: S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal: Proc Natl Acad Sci U S A Date: 1981-05 Impact factor: 11.205

11 in total

1. Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A1 receptor ligands.

Authors: A Dalpiaz; A Scatturin; B Pavan; K Varani; A P IJzerman; P Andrea Borea
Journal: Pharm Res Date: 1999-07 Impact factor: 4.200

Novel therapeutics acting via purine receptors.

1. Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.

2. The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure.

3. Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists.

4. CGP 22979A, a renal vasodilator with natriuretic properties.

5. Sleep improvement in dogs after oral administration of mioflazine, a nucleoside transport inhibitor.

6. Coronary and cardiohemodynamic effects of 2-phenylamino-adenosine (CV-1808) in anesthetized dogs and cats.

7. Impaired blood flow autoregulation in nonfiltering kidneys: effects of theophylline administration.

8. Consequences of activation and adenosine-mediated inhibition of granulocytes during myocardial ischemia.

9. Adenosine stimulates sodium transport in kidney A6 epithelia in culture.

10. Adenosine receptors and behavioral actions of methylxanthines.

1. Thermodynamic in vitro studies as a method to investigate the pharmacodynamic behavior of adenosine A1 receptor ligands.

Review 2. Folate, antifolates, and folate analogs in pediatric oncology.

3. Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.

4. Synthesis and study of 5'-ester prodrugs of N6-cyclopentyladenosine, a selective A1 receptor agonist.

5. Attenuation of ischemic liver injury by augmentation of endogenous adenosine.

6. The diuretic action of 8-cyclopentyl-1,3-dipropylxanthine, a selective A1 adenosine receptor antagonist.

7. Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo.

Review 8. Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Review 9. Adenosine A1 and A2 receptors: structure--function relationships.

10. Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.